NAFDAC relays Pakistani recall of four medicine batches to Nigerian market
Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the market to four batches of medicines
Alerts & Recalls
Alerts & Recalls
Alerts & Recalls
Egypt recalls Rameda Vilaphoria 40mg batch after laboratory non-conformity
The Egyptian Drug Authority (EDA) has ordered a Class II recall of one batch of Vilaphoria 40mg film-coated tablets, manufactured
Alerts & Recalls
Egypt orders Class I recall of Appavisc HVPFS batch after failing lab testing
The Egyptian Drug Authority (EDA) has ordered a Class I recall of one batch of Appavisc HVPFS, manufactured by Chironephre
Alerts & Recalls
South Sudan Orders Immediate Recall of Duphaston and Navidoxine Over Quality and Falsification Concerns
South Sudan recalls Duphaston and Navidoxine over quality and falsification concernsSouth Sudan’s Drug and Food Control Authority (DFCA) has ordered
Alerts & Recalls
Somalia Pharmaceutical Business Council Warns Falsified Brands Could Damage Reputation of Pakistani Medicines
SPBC urges Pakistan’s pharmaceutical industry to address alleged brand falsification in Somalia, warning that the conduct of individual traders could undermine confidence in legitimate Pakistani medicines.
Alerts & Recalls
Mozambique withdraws Remedica methyldopa tablets after black spots found
Mozambique’s National Medicines Regulatory Authority (ANARME) has ordered the immediate suspension of sale and withdrawal from the national market of
Alerts & Recalls
BoMRA recalls Flumed Syrup batch after crystallisation found
One batch of the paracetamol-based combination cough and cold syrup, made by Varichem Pharmaceuticals of Zimbabwe, has been recalled from the Botswana market.
Alerts & Recalls
NAFDAC alerts market to falsified products imitating Forxiga
Nigeria’s National Agency for Food and Drug Administration and Control (NAFDAC) has warned that suspected falsified products imitating Forxiga (dapagliflozin)
Alerts & Recalls
SAHPRA recalls four batches of Enalapril 10mg Arya over specification failure
Post-marketing surveillance found out-of-specification results in the hypertension medicine; the Class II recall covers four batches of 28-tablet packs, two of which remain in date.
Alerts & Recalls
Somaliland suspends sale of YENISOM medicines over missing quality testing
The order covers YENISOM Healthcare’s entire range rather than named batches, and the agency says the ground is procedural: required entry testing was not carried out.